Literature DB >> 10341184

New cryptosporidium genotypes in HIV-infected persons.

N J Pieniazek1, F J Bornay-Llinares, S B Slemenda, A J da Silva, I N Moura, M J Arrowood, O Ditrich, D G Addiss.   

Abstract

Using DNA sequencing and phylogenetic analysis, we identified four distinct Cryptosporidium genotypes in HIV-infected patients: genotype 1 (human), genotype 2 (bovine) Cryptosporidium parvum, a genotype identical to C. felis, and one identical to a Cryptosporidium sp. isolate from a dog. This is the first identification of human infection with the latter two genotypes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10341184      PMCID: PMC2640774          DOI: 10.3201/eid0503.990318

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  10 in total

1.  A workbench for multiple alignment construction and analysis.

Authors:  G D Schuler; S F Altschul; D J Lipman
Journal:  Proteins       Date:  1991

2.  Ribosomal RNA gene organization in Cryptosporidium parvum.

Authors:  S M Le Blancq; N V Khramtsov; F Zamani; S J Upton; T W Wu
Journal:  Mol Biochem Parasitol       Date:  1997-12-15       Impact factor: 1.759

3.  Massive outbreak of waterborne cryptosporidium infection in Milwaukee, Wisconsin: recurrence of illness and risk of secondary transmission.

Authors:  W R MacKenzie; W L Schell; K A Blair; D G Addiss; D E Peterson; N J Hoxie; J J Kazmierczak; J P Davis
Journal:  Clin Infect Dis       Date:  1995-07       Impact factor: 9.079

4.  Genetic markers differentiate C. parvum isolates.

Authors:  M Carraway; G Widmer; S Tzipori
Journal:  J Eukaryot Microbiol       Date:  1994 Sep-Oct       Impact factor: 3.346

5.  PCR cloning and nucleotide sequence determination of the 18S rRNA genes and internal transcribed spacer 1 of the protozoan parasites Cryptosporidium parvum and Cryptosporidium muris.

Authors:  J Cai; M D Collins; V McDonald; D E Thompson
Journal:  Biochim Biophys Acta       Date:  1992-07-15

6.  Declining CD4+ T-lymphocyte counts are associated with increased risk of enteric parasitosis and chronic diarrhea: results of a 3-year longitudinal study.

Authors:  T R Navin; R Weber; D J Vugia; D Rimland; J M Roberts; D G Addiss; G S Visvesvara; S P Wahlquist; S E Hogan; L E Gallagher; D D Juranek; D A Schwartz; C M Wilcox; J M Stewart; S E Thompson; R T Bryan
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1999-02-01

7.  Genotypic and phenotypic characterization of Cryptosporidium parvum isolates from people with AIDS.

Authors:  G Widmer; S Tzipori; C J Fichtenbaum; J K Griffiths
Journal:  J Infect Dis       Date:  1998-09       Impact factor: 5.226

8.  Molecular characterization of Cryptosporidium isolates from humans and other animals using random amplified polymorphic DNA analysis.

Authors:  U M Morgan; C C Constantine; P O'Donoghue; B P Meloni; P A O'Brien; R C Thompson
Journal:  Am J Trop Med Hyg       Date:  1995-06       Impact factor: 2.345

9.  Cryptosporidium wrairi sp. n. from the guinea pig Cavia porcellus, with an emendation of the genus.

Authors:  J M Vetterling; H R Jervis; T G Merrill; H Sprinz
Journal:  J Protozool       Date:  1971-05

Review 10.  Cryptosporidiosis in humans: review of recent epidemiologic studies.

Authors:  T R Navin
Journal:  Eur J Epidemiol       Date:  1985-06       Impact factor: 8.082

  10 in total
  51 in total

1.  Evaluation of ColorPAC Giardia/Cryptosporidium rapid assay and ProSpecT Giardia/Cryptosporidium microplate assay for detection of Giardia and Cryptosporidium in fecal specimens.

Authors:  M T Katanik; S K Schneider; J E Rosenblatt; G S Hall; G W Procop
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

2.  Phylogenetic relationships of Cryptosporidium parasites based on the 70-kilodalton heat shock protein (HSP70) gene.

Authors:  I M Sulaiman; U M Morgan; R C Thompson; A A Lal; L Xiao
Journal:  Appl Environ Microbiol       Date:  2000-06       Impact factor: 4.792

3.  Morphologic, host specificity, and molecular characterization of a Hungarian Cryptosporidium meleagridis isolate.

Authors:  T Sréter; G Kovács; A J da Silva; N J Pieniazek; Z Széll; M Dobos-Kovács; K Márialigeti; I Varga
Journal:  Appl Environ Microbiol       Date:  2000-02       Impact factor: 4.792

Review 4.  In vitro cultivation of cryptosporidium species.

Authors:  Michael J Arrowood
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

5.  Development of procedures for direct extraction of Cryptosporidium DNA from water concentrates and for relief of PCR inhibitors.

Authors:  Jianlin Jiang; Kerri A Alderisio; Ajaib Singh; Lihua Xiao
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792

6.  Cryptosporidium infection: diagnostic techniques.

Authors:  Barbara Magi; Valentina Canocchi; Giacinta Tordini; Carla Cellesi; Angela Barberi
Journal:  Parasitol Res       Date:  2005-11-18       Impact factor: 2.289

7.  Genotypes of Cryptosporidium species infecting fur-bearing mammals differ from those of species infecting humans.

Authors:  Ling Zhou; Ronald Fayer; James M Trout; Una M Ryan; Frank W Schaefer; Lihua Xiao
Journal:  Appl Environ Microbiol       Date:  2004-12       Impact factor: 4.792

8.  Detection of cryptosporidium and identification to the species level by nested PCR and restriction fragment length polymorphism.

Authors:  Stephane Coupe; Claudine Sarfati; Samia Hamane; Francis Derouin
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

9.  Identification of Cryptosporidium spp. oocysts in United Kingdom noncarbonated natural mineral waters and drinking waters by using a modified nested PCR-restriction fragment length polymorphism assay.

Authors:  R A B Nichols; B M Campbell; H V Smith
Journal:  Appl Environ Microbiol       Date:  2003-07       Impact factor: 4.792

10.  Host-adapted Cryptosporidium spp. in Canada geese (Branta canadensis).

Authors:  Ling Zhou; Hailu Kassa; Monica L Tischler; Lihua Xiao
Journal:  Appl Environ Microbiol       Date:  2004-07       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.